Get the app
US › Healthcare

Alector Inc (ALEC)

US · Healthcare · Biotechnology

$1.84-3.66%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.3M
Revenue YoY
-57.8%
Net profit
$-23.0M
EPS
$-0.21
EPS estimate
$-0.24
Net margin
-692.5%

EPS came in at -0.21 against a street estimate of -0.24 — a beat of 12.5%.

Key statistics

Market cap
$205.4M
Forward P/E
8.5
P/B
19.57
Book value
$-0.09
EPS (TTM)
$-1.09
52-week high
$3.33
52-week low
$1.09
50-day MA
$2.09
200-day MA
$2.02
Beta
0.62

Analyst view

Analysts rate Alector Inc a hold (3 buy, 2 hold, 2 sell out of 7) with an average price target of $3.30.

Shareholding

Insiders
9.52%
Institutions
93.29%

Largest institutional holders

FundStake
TCG Crossover Management, LLC8.96%
Nantahala Capital Management, LLC7.73%
BlackRock Inc7.03%
Acadian Asset Management LLC3.95%
Vanguard Capital Management, LLC3.59%
Kynam Capital Management, LP3.41%
Merck & Co Inc3.18%
Balyasny Asset Management LLC2.91%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alector Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.